Concepedia
Statistics
Publications
30
Citations
9K
H-Index
26
Active since
2003
Affiliations
Stanford University(Current)
University of North Carolina at Chapel Hill
California Institute for Regenerative Medicine
Institute for Stem Cell Biology and Regenerative Medicine
Stanford Medicine
Stephen B. Willingham is an author at Stanford University specializing in immunology, oncology, and life sciences.
Publications per year
2003–2022
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
Stephen B. Willingham, Jens-Peter Volkmer, Andrew J. Gentles et al. · Proceedings of the National Academy of Sciences · 2012 · 1.7K citations · Full text
Medicine, Immunology, Oncology +17
Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47
Mark P. Chao, Siddhartha Jaiswal, Rachel Weissman-Tsukamoto et al. · Science Translational Medicine · 2010 · 760 citations
Life Sciences, Immunology, Oncology +11
Cutting Edge: Inflammasome Activation by Alum and Alum’s Adjuvant Effect Are Mediated by NLRP3
Hanfen Li, Stephen B. Willingham, Jenny P.‐Y. Ting et al. · The Journal of Immunology · 2008 · 653 citations · Full text
Life Sciences, Immunology, Pathology +17
Anti-CD47 antibody–mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response
Diane Tseng, Jens-Peter Volkmer, Stephen B. Willingham et al. · Proceedings of the National Academy of Sciences · 2013 · 649 citations · Full text
Life Sciences, Immunology, Oncology +17
Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling
Joseph A. Duncan, Dan T. Bergstralh, Yanhong Wang et al. · Proceedings of the National Academy of Sciences · 2007 · 491 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +8
1–5 of 30